Kurve Therapeutics, Inc. — Regulation A 1-A/A
Kurve Therapeutics, Inc. of LYNNWOOD, WA filed a Regulation A 1-A/A with the SEC on 2022-07-29. Aggregate offering: $50.0M (Tier 2). Industry: Other.
Offering
- Filed: 2022-07-29
- Form: 1-A/A
- Accession: 0001930260-22-000003
- Tier: Tier 2
- Total aggregate offering: $50.0M
- Issuer portion: $42.4M
- Selling securityholders: $7.6M
- Price per security: $5.8000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Assurance Dimensions
- Jurisdictions: 128 states/territories
Issuer
- CIK: 0001930260
- Organized in: DE
- Incorporated: 2019
- Address: 16825 48TH AVE WEST, LYNNWOOD, WA, 98037
- Phone: 4256409249
- Employees: 1 full-time
Financial snapshot (as filed)
- Total assets: $641K
- Cash & equivalents: $374K
- Total liabilities: $607K
- Stockholder equity: $34K
- Revenues: $71K
- Net income: $-65K
People (1)
| Name | Role | Location |
|---|
| Nicholas Antaki | Signer | SCOTTSDALE, AZ |
Other Reg A filings by this issuer (1)
More